Safe Handling of Hazardous Drugs
|
|
|
- Dinah Hopkins
- 9 years ago
- Views:
Transcription
1 Safe Handling of Hazardous Drugs Staff Education May 1, 2015
2 Safe Handling of Hazardous Drugs Most hospitals have policies & procedures for the handling of cytotoxic drugs (chemotherapy) But what about those other drugs. Other medications that have been acknowledged as potentially hazardous
3 Goals 1. Understand what information is in the new Safe Handling of Hazardous Medications Policy. 2. Define what a Hazardous Medication is and what some of the risks of occupational exposure are. 3. Use the policy to determine: the classification of the Hazardous Medication the dosage form of the Hazardous Medication how that impacts the handling precautions required to minimize occupational exposure.
4 Goal of Policy To establish processes and requirements to support the safe handling of hazardous drugs, including procurement, transport, preparation, dispensing, administration, clean-up (spills) and disposal.
5 WHO does this policy apply to? ALL employees providing direct care to patients receiving Hazardous Medications (nursing assistants, nurses, physicians, physiotherapy, etc.). ALL employees handling or transporting medication, waste or soiled equipment (e.g. housekeeping, laundry, transport, pharmacy, shipping and receiving, etc.).
6 WHEN Does this Policy Apply Greatest risk activities: preparation and administration of medication. Lesser risk activities: handling human waste of patients known to have received a hazardous medication in the last 48 hours. Staff should ensure they are wearing appropriate personal protective equipment (PPE) for each of these levels of exposure.
7 Hazardous Drugs Medications that are known or suspected to cause adverse health effects from exposures in the workplace. They include: Antineoplastic and chemotherapy medications used for cancer and other diseases Medications to treat auto immune diseases like arthritis Some antiviral medications, hormones, some bioengineered medication & other miscellaneous medications.
8 Cytotoxic and Non-Cytotoxic Hazardous Drugs Cytotoxic Hazardous Drug NON-Cytotoxic Hazardous Drug Drugs that are detrimental or destructive to cells within the body (e.g. cytotoxic, mutagenic, genotoxic or carcinogenic). These agents are commonly used in cancer treatment but may also be used for other disorders. Deemed to pose maximal risk in the event of occupational exposure. Medications (other than cytotoxic hazardous medications) that adversely affect the reproductive system (e.g. teratogenicity, impaired fertility), endocrine system, immune system, respiratory system or have potential to transmit infection. Deemed to pose a potential risk in the event of occupational exposure and require special handling precautions
9 What are the POTENTIAL Risks to Health Care Workers? Working with or near hazardous medications in health care settings can potentially cause: Skin rashes Infertility Miscarriage Birth defects Organ toxicities Leukemia or other cancers
10 How Would I Come into Contact with a Hazardous Drug? Direct contact Primary physical contact with a hazardous medication during preparation or administration or when managing a hazardous medication spill. Touching measurable concentrations of medications present on drug vial exteriors, work surfaces, floors, and final medication products? Indirect Contact Secondary contact with a hazardous medication from body fluids, bed linens, medical equipment, etc. Changing the diaper of a baby receiving cytotoxic medication for leukemia
11 There are 3 Key Steps to Consider When Handling Hazardous Drugs Step 1 Determine if the drug is on the Hazardous Drugs List and if it is Cytotoxic or Non-Cytotoxic (Appendix A) Step 2 - Determine the dose form of the drug that you are going to handle. Step 3 Refer to the Handling Precautions for Hazardous Drug Chart (Appendix B) and follow directions for the process you are about to complete.
12 Step 1 - Is the medication that I m handling Hazardous? There are 4 ways that you can learn if the drug you are handling is Hazardous 1 Refer to the Cytotoxic and NON-Cytotoxic Hazardous Drug List (Appendix A)
13 Step 1 - Is the medication that I m handling Hazardous? 2. Look for a symbol: or 3. Refer to the orders tab: 4. Refer to the emar:
14 Step 1 You will also know that the patient you are caring for has received a hazardous drug and that you need to take precautions, by the Precaution sign outside of the patients room
15 Step 2 Determine Dosage Form Is this drug an Injectable dosage form? (e.g. IV, IM, SQ, IT, bladder instillation etc.) Refer to the Injections section of the handling precautions chart:
16 Step 2 Determine Dosage Form Is it a Compromised dosage form? (e.g. oral liquids, splitting, crushing a tablet, opening a capsule, compounding, dissolve-and administer and topical products). Refer to the Compromised Dosage Form section of the chart:
17 Step 2 - Compromised Dose Forms Pharmacy will purchase or prepare a liquid dosage form if required for your patient. If this is not available, they may suggest the Dissolveand-Administer (refer to Appendix C) Contact pharmacy for full instructions on using this method and to ensure that the medication can be administered in this manner.
18 Dissolve-and-Administer Dissolve-and-administer to be prepared by nurse on floor when: - Tablet(s)/capsule(s) easily dissolve in water AND - Total resultant volume is to be administered (See Section 1) Dissolve-and-administer is to be prepared by pharmacy when: - Tablet(s)/capsule(s) must be crushed/opened OR - Partial resultant volume is to be administered (See Sections 2-4) Procedure for Nursing: Don PPE and arrange materials on plasticbacked pad at the patient s bedside Remove plunger from oral syringe Place tablets/capsule in syringe without crushing/opening Insert plunger into syringe barrel Draw water into syringe as directed then draw additional 1mL of air. Place cap on tip of syringe Shake syringe and let sit for 2-5 minutes, then shake again to dissolve Administer dose directly from syringe Draw up additional water into syringe, shake and administer to ensure entire dose given Discard syringe into appropriate disposal
19 Step 2 Determine Dosage Form Is the drug in an oral solid, intact dosage form? (e.g. tablet or capsule) and supplied as a Unit Dose package, no further manipulation of drug is required Refer to the Intact Oral Dosage Forms section of the handing precautions chart (appendix B) NOTE: If a solid oral intact dosage form is not appropriate for administration to your patient (cannot swallow tablet, medication is administered through a feeding tube, etc.) DO NOT CRUSH TABLET or OPEN CAPSULE and Contact pharmacy for assistance
20 Step 3 Follow the Handling Precautions Referring to the Handling Precautions for Hazardous Drugs Chart (Appendix) find the process you are about to complete for the specified category of drug and follow the instructions. e.g. For cyclophosphamide injection the nurse would follow the instructions circled here:
21 Summary Key Points Hazardous medications can potentially cause harm to workers. Hazardous medications can be classified as cytotoxic and non-cytotoxic. There are 3 steps staff members need to be aware of when handling these agents.
22 Other Key Points Be familiar with the policy. Report any exposure (direct and indirect contact / skin puncture) with hazardous medication to immediate supervisor and complete AEMS Discuss concerns about pregnancy, breast-feeding or planned pregnancy with your supervisor - may lead to temporary reassignment.
23 The List THE LIST Appendix A
24 HANDLING Appendix B
25 HANDLING page 2 Appendix B
26 Resources Link for policy: Contact a member of out team if you have questions Sandy Jansen Cathy Stark Jill Craven Ally Dhalla Jennifer Newman Nadia Facca Charlene Jones Andy DiCarlo Pat Stalker Gail Judd Krista Biederman Monica Kaszycki Michelle Gratton Policy Go-live May 1, 2015
27 Questions?
SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010
SAFE HANDLING OF HAZARDOUS MEDICATIONS Cytotoxic and Non-Cytotoxic Winnipeg Regional Health Authority Policy # 110.160.010 By the end of this presentation staff should be able to 1. Understand what information
Cytotoxic Agents Safe Management For Nursing Students. Pat Stalker Clinical Educator, LRCP Feb 2015
Cytotoxic Agents Safe Management For Nursing Students Pat Stalker Clinical Educator, LRCP Feb 2015 Overview and Objectives Review key content of the nursing procedure Differentiate between Hazardous drugs
To provide direction for the safe handling, administration and disposal of hazardous drugs.
Subsection: MEDICATION Related terms: Cytotoxic Drugs, Antineoplastic Drugs Authorized by: Clinical Directors CS-04-02-01 Page 1 of 9 Date Established: October 2006 Date For Review: September 2014 Dates
INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HANDLING OF H AZARDOUS DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED
Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช
Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช Chemotherapy Agent. Low therapeutic index. -Increase risk for medication error. Hazardous
Safe Handling of Cytotoxic Materials
Safe Handling of Cytotoxic Materials Kara Henman RN, MN, CON(C) Oncology Practice Consultant Cancer Care Nova Scotia What are hazardous drugs? Chemotherapy Immunosuppressive agents Biological agents Antiviral
Safe Handling of Oral Chemotherapy. Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL Rick.abbott@easternhealth.
Safe Handling of Oral Chemotherapy Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL [email protected] Conflict of Interest Declaration I have developed and delivered
Recommendations for the Safe Use of Handling of Cytotoxic Drugs
Recommendations for the Safe Use of Handling of Cytotoxic Drugs Introduction Cytotoxic drugs are toxic compounds and are known to have carcinogenic, mutagenic and/or teratogenic potential. With direct
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
Hazardous Precautions. Prepared By: Hazardous Precautions Working Group Updated: March 2014
Hazardous Precautions Prepared By: Hazardous Precautions Working Group Updated: March 2014 1 What are Hazardous Medications? They are therapeutic agents that are often used in the treatment of: cancer,
Classification of Hazardous Drugs by NIOSH
Classification of Hazardous Drugs by NIOSH Thomas H. Connor, PhD Research Biologist National Institute for Occupational Safety and Health NIOSH Goals Protect workers from exposure to hazardous drugs Provide
Cytotoxic Precautions at Home A Guide for Cancer Patients and Families
Cytotoxic Precautions at Home A Guide for Cancer Patients and Families Your cancer treatment... 1 What are cytotoxic precautions?... 1 What body fluids are cytotoxic?... 1 How do I handle my body wastes?...
This course was written for RN.ORG by an outside consultant and RN.ORG has rights for distribution but is not responsible for the contents.
Safe Handling of Hazardous Drugs WWW.RN.ORG Reviewed September, 2015, Expires September, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG,
PHARMACY TECHNICIAN COURSE DESCRIPTIONS
PHARMACY TECHNICIAN COURSE DESCRIPTIONS OCCUPATIONAL COMPLETION POINTS AND PROGRAM LENGTH: * Basic Healthcare Worker OCP A 90 Hours (COURSE #HSC 0003) * Community Pharmacy Technician OCP B 360 Hours (COURSE
Safe Disposal Methods Management of Body Substances from Patients Undergoing and Following Cytotoxic Drug Therapy Background Hospital/ Institution Home Physician Nurse Nurse Aide Personnel handling waste
El Paso - Ambulatory Clinic Policy and Procedure
Regulation Reference: El Paso - Ambulatory Clinic Policy and Procedure Title: Disposal of Expired Medications Policy Number: EP 3.5 Policy Statement: Effective Date: 8/1/2014 It is the policy of Texas
INTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure
INTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure TITLE: Safe Handling of Cytotoxic Drugs/Waste NUMBER: CC 05-055 Date Issued: August 2011 Page 1 of 11 Applies To: Holders of Interdisciplinary Clinical
PHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM
PHARMACEUTICAL WASTE MANAGEMENT DUKE UNIVERSITY HEALTH SYSTEM BLUE BIN DRUGS ONLY NO EMPTY Packages, NO Gloves NO Scissors, Syringes, Needles, IVs Scalpels, Forceps BLUE BIN PROGRAM PURPOSE AND OBJECTIVE:
Minimizing Occupational Exposure to Hazardous Chemicals in Animal Protocols
Environmental Health and Safety Minimizing Occupational Exposure to Hazardous Chemicals in Animal Protocols Chemicals that are highly toxic or corrosive, known or suspected carcinogens, reproductive hazards,
Administering Medications
Administering Medications Pharmacology for Healthcare Professionals seventh edition Donna F. Gauwitz, R.N., Nursing Consultant Senior Teaching Specialist of Nursing University of Minnesota Minnesota and
Policies and Procedures. I.D. Number: 1044
Policies and Procedures Title: HAZARDOUS DRUGS (Non-Chemotherapy) ADMINISTRATION AND PRECAUTIONS I.D. Number: 1044 Authorization: [X] SHR Nursing Practice Committee Source: Nursing Date Revised: November
Preparation and Handling of Cytotoxic, Hazardous and Potentially Hazardous Medicines Policy
Department of Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM Preparation and Handling of Cytotoxic, Hazardous and Potentially Hazardous Medicines Policy SDMS
Standard Operating Procedure for Dacarbazine in Animals
Standard Operating Procedure for Dacarbazine in Animals 1. Health hazards Dacarbazine, also known as DTIC, DIC, and Imidazole Carboxamide, is an antineoplastic chemotherapy drug used in the treatment of
ZOVIRAX Cold Sore Cream
Data Sheet ZOVIRAX Cold Sore Cream Aciclovir 5% w/w Presentation Topical cream Indications ZOVIRAX Cold Sore Cream is indicated for the treatment of Herpes simplex virus infections of the lips and face
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES
Perth and Smiths Falls District Hospital Attention: Manager, Quality 60 Cornelia Street, West Smiths Falls, Ontario K7A 2H9 CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES This guide has been prepared
MA 2000 Pharmacology for Medical Assistants
South Central College MA 2000 Pharmacology for Medical Assistants Course Information Description Total Credits 3.00 Total Hours 64.00 Types of Instruction In this course students will learn topics essential
British Columbia Cancer Agency
Page 1 of 8 RATIONALE To minimize the hazardous drug exposure of staff, patients and visitors to the BCCA Regional Centres, spills must be managed appropriately, according to established policies and procedures.
Maryland Department of Health and Mental Hygiene 201 W. Preston Street Baltimore, Maryland 21201
STATE OF MARYLAND DHMH Maryland Department of Health and Mental Hygiene 201 W. Preston Street Baltimore, Maryland 21201 Martin O Malley, Governor Anthony G. Brown, Lt. Governor Joshua M. Sharfstein, M.D.,
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Blood/Bodily Fluid Exposure and Needlestick Injury Policy Statement & HIV PEP Kit Dispensing Guideline
Blood/Bodily Fluid Exposure and Needlestick Injury Policy Statement & HIV PEP Kit Dispensing Guideline Providing certain services in a pharmacy, especially injections, carries a risk for the pharmacist
HAZARD COMMUNICATION & THE GLOBAL HARMONIZING SYSTEM EMPLOYEE TRAINING
HAZARD COMMUNICATION & THE GLOBAL HARMONIZING SYSTEM EMPLOYEE TRAINING This easy-to-use Leader s Guide is provided to assist in conducting a successful presentation. Featured are: INTRODUCTION: A brief
What is a hazardous drug? Hazardous Drugs: NIOSH. Pharmaceutical Waste: Hazardous pharmaceutical Waste 衛 福 部 疾 病 管 制 署
殘 餘 藥 物 之 處 置 衛 福 部 疾 病 管 制 署 中 區 傳 染 病 防 治 醫 療 網 王 任 賢 指 揮 官 What is a hazardous drug? ASHP 2004 TAB criteria for considering a drug hazardous (adopted by OSHA): 1. Carcinogenicity 2. Teratogenicity 3.
Chemotherapy Spill Response:
Chemotherapy Spill Response: Antineoplastic Spills Outside Of A Fume Hood Lisa Hudley, RN Training Coordinator Safety & Environmental Compliance William Guess Director Safety & Environmental Compliance
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland Pharmacy/Patient Care Objectives Understand the background and regulatory requirements Identify pharmaceutical waste and how to dispose
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS 5 th Edition November 2015 NHS Pharmaceutical Quality Assurance Committee 2015 British Oncology Pharmacists Association Pharmaceutical
Connecticut Biomedical Waste (BMW) Requirements (22a-209-15) and Common Industry Practices
Connecticut Biomedical Waste (BMW) Requirements (22a-209-15) and Common Industry Practices Mark Latham CT DEP, Waste Engineering and Enforcement Division Common Synonyms for BMW Regulated Medical Waste
Spillage Waste Management
Spillage Waste Management Patient Information Introduction This leaflet contains the answers to some questions patients and carers may have about the disposal of chemotherapy waste and the management of
Health and safety practices for health-care personnel and waste workers
12 Health and safety practices for health-care personnel and waste workers 12.1 Principles Health-care waste management policies or plans should include provision for the continuous monitoring of workers
Vanderbilt University Medical Center Pharmaceutical Waste Program USER INSERVICE
Vanderbilt University Medical Center Pharmaceutical Waste Program USER INSERVICE Training and Education Plan This session is intended to train and provide super-users with necessary resources to effectively
DO YOU WORK AROUND BLOOD OR BODY FLUIDS? Cal/OSHA s New Rules
DO YOU WORK AROUND BLOOD OR BODY FLUIDS? Cal/OSHA s New Rules Labor Occupational Health Program University of California, Berkeley 1994 ACKNOWLEDGMENTS This booklet is a publication of the Labor Occupational
Hazardous Materials Management Considerations in Healthcare
Session No. 656 Introduction Hazardous Materials Management Considerations in Healthcare Mae Ping Grogg, MS, CSP BJC HealthCare St. Louis, MO 63110 Paul Halliburton, MS, CHMM Barnes-Jewish Hospital St.
INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED BY APPLIES
Tools for Policy Development: Recommendations for handling linens exposed to hazardous drugs
Tools for Policy Development: Recommendations for handling linens exposed to hazardous drugs What is your laundry s policy for handling linens that may have been exposed to hazardous drugs? This question
Chemotherapy: Safety Protocols. Janet Modrakovic, BAS, CVT
Chemotherapy: Safety Protocols Janet Modrakovic, BAS, CVT The word chemotherapy strikes fear in the heart of every pet owner whose beloved pet has been diagnosed with cancer. The incidence of cancer in
4729-16-11 Hazardous Drugs Compounded by a Prescriber.
ACTION: Original DATE: 11/30/2015 8:57 AM 4729-16-11 Hazardous Drugs Compounded by a Prescriber. (A) A facility where a prescriber is compounding or handling hazardous drugs shall be licensed as a terminal
Safe Management of Healthcare Waste A Guide to Good Practice in Secondary Care (England and Wales) January 2008
Safe Management of Healthcare Waste A Guide to Good Practice in Secondary Care (England and Wales) January 2008 The Department of Health Document Safe Management of Healthcare Waste was released in December
DISPENSING HIGH RISK/ALERT MEDICATIONS. Lana Gordineer, MSN, RN Diabetes Educator
DISPENSING HIGH RISK/ALERT MEDICATIONS Lana Gordineer, MSN, RN Diabetes Educator HIGH RISK/ALERT MEDICATIONS (or DRUGS) Medications that have a high risk of causing serious injury or death to a patient
WINDEX ORIGINAL GLASS CLEANER WITH AMMONIA-D
1. PRODUCT AND COMPANY IDENTIFICATION Product information Product name : WINDEX ORIGINAL GLASS CLEANER WITH AMMONIA- D Recommended use : Hard Surface Cleaner Manufacturer, importer, supplier : S.C. Johnson
Methotrexate. What is methotrexate?
Methotrexate What is methotrexate? Methotrexate is a mild immunosuppressant that also exhibits antiinflammatory activity. Methotrexate is commonly used for the treatment of certain cancers including but
Standard Operating Procedure for the Use of Particularly Hazardous Drugs/Chemicals in Animals
1. Purpose Standard Operating Procedure for the Use of Particularly Hazardous Drugs/Chemicals in Animals PO Box 245101 Tucson, AZ 85724-5101 Voice: (520) 626-6850 FAX: (520) 626-2583 rlss.arizona.edu Exposure
INSTITUTIONAL POLICY AND PROCEDURE (IPP)
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HAZARDOUS WASTE: HANDLING AND DISPOSAL EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO.
Guidelines for the Management of Spillage of Cytotoxic Drugs. No changes have been made as evidence base remains current.
Guidelines for the Management of Spillage of Cytotoxic Drugs Date Approved by Network Governance May 2012 Date for Review May 2015 Changes Between Versions 3.0 and 4.0 No changes have been made as evidence
INJECTION TECHNIQUE. IVF NURSING OFFICE: (301) 400-2151 Darshana (301) 400-2146 Nicole
IVF NURSING OFFICE: (301) 400-2151 Darshana (301) 400-2146 Nicole PLEASE NOTE: If you do not have medications for the next day s dose, you MUST go to the clinic that morning at 6:30 AM for more medications.
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. PRODUCT IDENTIFICATION 1.1 Product Name: Cyanogen Bromide Fibrinogen Fragments 1.2 Product REF: 459 1.3 Configuration: One (1) vial, 5.0 mg, lyophilized 1.4 Use of Product:
Work Health and Safety Regulations: Classification and labelling for workplace hazardous chemicals
code* word Class Category Code* Text Unstable explosive H200 Unstable explosive Division 1.1 H201 Explosive; mass explosion hazard Division 1.2 H202 Explosive; severe projection hazard Explosives Division
Methotrexate Dose For Juvenile Rheumatoid Arthritis
Methotrexate Dose For Juvenile Rheumatoid Arthritis should i take methotrexate for my ra methotrexate 50 mg/ml methotrexate sodium 2.5mg tablets what is the usual dosage of methotrexate for ra methotrexate
University of Kentucky / UK HealthCare Policy and Procedure. Policy # A14-065
University of Kentucky / UK HealthCare Policy and Procedure Policy # A14-065 Title/Description: Chemotherapy and Hazardous Medication Use Process Purpose: To standardize work processes that incorporate
WHMIS After GHS: Preparing for Change. Canadian Centre for Occupational Health and Safety
WHMIS After GHS: Preparing for Change Canadian Centre for Occupational Health and Safety 1. About this publication WHMIS is changing. The substance of WHMIS (labels, MSDSs, and training) will remain, but
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014 ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ HAZARD? HAZARD ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ ENCLOSURE Substitution ส งค กคามซ งอาจเป นอ นตรายต
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
WINDEX MULTI-SURFACE CLEANER - VINEGAR
1. PRODUCT AND COMPANY IDENTIFICATION Product information Trade name : Use of the : Hard Surface Cleaner Substance/Mixture Company : S.C. Johnson and Son, Limited 1 Webster Street Brantford ON N3T 5R1
PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)
PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable
How To Take Methotrexate By Injection
How To Take Methotrexate By Injection 1 how long does it take for methotrexate to work for abortion 2 methotrexate 15 mg hair loss 3 methotrexate injection dosage for rheumatoid arthritis 4 order methotrexate
IVF CLASS. IVF NURSE CONTACT INFORMATION: Darshana 301-400-2151, [email protected] Nicole 301-400-2146, nicole.l.sobers.ctr@health.
IVF CLASS IVF NURSE CONTACT INFORMATION: Darshana 301-400-2151, [email protected] Nicole 301-400-2146, [email protected] PLEASE NOTE: If you do not have medications for the next
PRODUCT ID: LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION
SECTION 15: REGULATORY INFORMATION This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all the information required by the
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Cytotoxic and Biotherapies Credentialing Programme Module 6
Cytotoxic and Biotherapies Credentialing Programme Module 6 1. Safe Handling and Administration of Cytotoxic and Biotherapies 2. Waste and Spill Management At the completion of this module the RN will
Biohazardous Waste and Sharps Disposal
Biohazardous Waste and Sharps Disposal Federal OSHA Occupational Exposure to Bloodborne Pathogens Standard 29 CFR 1910.1030 State California Code of Regulations (CCR), Medical Waste Management Act, Chapter
APPENDIX A GUIDANCE DOCUMENT
APPENDIX A GUIDANCE DOCUMENT Infectious Substances International Civil Aviation Organization Technical Instructions for the Safe Transport of Dangerous Goods by Air, 2005-2006 Note: This guidance document
1. Identification of the substance/preparation and the company/undertaking
MSDS Check-Direct CPE (Catalog no. 18-0080) 4-Color Compensation Set for Check-Direct CPE (Catalog no. 18-0070) 1. Identification of the substance/preparation and the company/undertaking Product name Supplier
Patient Information Leaflet
Patient Information Leaflet METHOTREXATE We hope this fact sheet will provide you with some information about Methotrexate and answer some of the questions you may have. Methotrexate is available in tablet
Mold. Clean Up, Removal, Safety Concerns
Mold & Clean Up, Removal, Safety Concerns What is Mold? What are the Symptoms? Should I be concerned? What is Toxic Mold? Molds are fungi that can be found both indoors and outdoors. It s not know how
Bloodborne Pathogens Program Revised July, 5 2012
Bloodborne Pathogens Program Revised July, 5 2012 Page 1 of 16 Table of Contents 1.0 INTRODUCTION...3 1.1 Purpose...3 1.2 Policy.3 2.0 EXPOSURE CONTROL METHODS 4 2.1 Universal Precautions.4 2.2 Engineering
WINDEX COMMERCIAL LINE GLASS CLEANER WITH AMMONIA- D
1. PRODUCT AND COMPANY IDENTIFICATION Product information Trade name : WINDEX COMMERCIAL LINE GLASS CLEANER WITH AMMONIA- Use of the : Hard Surface Cleaner Substance/Mixture Company : S.C. Johnson & Son,
Position Statement: Safe handling of monoclonal antibodies in healthcare settings
Position Statement: Safe handling of monoclonal antibodies in healthcare settings Introduction Monoclonal antibodies (MABs) were introduced into clinical practice in the mid 1980s, with their use in the
Annual Biomedical Waste Code Training
Annual Biomedical Waste Code Training Provided by: Barbara D. Will, MPH Biomedical Waste Program Supervisor To protect, promote and improve the health of all people in Florida through integrated state,
Staff Skin Care Policy
This is an official Northern Trust policy and should not be edited in any way Staff Skin Care Policy Reference Number: NHSCT/10/350 Target audience: All Trust staff and in particular those involved in
Environmental Safety Division University of Georgia Right to Know Training
Course Overview All UGA employees are required to have basic Right To Know training for their protection. This course is designed to familiarize you with the basics of the Right to Know law covering university
Helping to protect you from exposure to hazardous drugs
Helping to protect you from exposure to hazardous drugs Closed system solution: Texium closed male luer and SmartSite needle-free valve products What you can t see can hurt you The risks are well documented
Guidance Document Infectious Substances
Guidance Document Infectious Substances Note: 1. The following Guidance Document was developed by the ICAO DGP. The original ICAO document reflects references to the ICAO Technical Instructions these have
NIH Clinical Center Patient Education Materials Giving a subcutaneous injection
NIH Clinical Center Patient Education Materials What is a subcutaenous injection? A subcutaneous injection is given in the fatty layer of tissue just under the skin. A subcutaneous injection into the fatty
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Reconstitution of Solutions
Chapter 12 Reconstitution of Solutions Reconstitution Process of mixing and diluting solutions Some medications supplied in powder form and must be mixed with liquid before administration Parts of Solutions
Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home
Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home Contents Page Important contact numbers 1 General information on preparing and administering IV antibiotics
MATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET SIMULATED INSULIN, REGULAR INSTRUCTIONAL USE ONLY. NOT FOR HUMAN OR ANIMAL USE 1. PRODUCT AND COMPANY IDENTIFICATION Product Name: Demo Dose Simulated Insulin, Regular Product
Learning to Self Inject Methotrexate at Home Developed by Andy Thompson MD FRCPC and Marie J Craig-Chambers B.Sc.Phm
Learning to Self Inject Methotrexate at Home Developed by Andy Thompson MD FRCPC and Marie J Craig-Chambers B.Sc.Phm Why might my Doctor ask me to inject Methotrexate? Methotrexate comes in two forms:
COMPOUNDING WITH HAZARDOUS DRUGS
VOLUME 15 NUMBER 2 Secundum Artem Current & Practical Compounding Information for the Pharmacist. An ongoing CE Program provided by a grant from Paddock Laboratories, Inc. COMPOUNDING WITH HAZARDOUS DRUGS
RULES OF DEPARTMENT OF COMMUNITY HEALTH HEALTHCARE FACILITY REGULATION
Disclaimer: This is an unofficial copy of the rules that has been provided for the convenience of the public by the Department of Community Health. The official rules for this program are on record with
WINDEX ORIGINAL GLASS CLEANER
1. PRODUCT AND COMPANY IDENTIFICATION Product information Trade name : Use of the : Hard Surface Cleaner Substance/Mixture Company : S.C. Johnson & Son, Inc. 1525 Howe Street Racine WI 53403-2236 Emergency
